Alkem Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For ALKEM, that strike is ₹5,300. Spot at ₹5,190 is 2.1% below max pain — possible upward gravitational pull into expiry.
Max Pain Level
The current max‑pain strike for Alkem Laboratories Limited (ALKEM) is ₹5,300. Max pain is the strike at which option writers would incur the smallest aggregate loss, acting like a magnet that can pull the underlying price toward it as expiry approaches.
Spot vs Max Pain Gap
The spot price of ₹5,190 sits about 2 % below the max‑pain level, indicating a modest upside pull‑back pressure as the contract nears expiry. If the underlying drifts upward, it would reduce the net loss for writers and align with the expected convergence.
Shift Signal
The max‑pain strike shows no shift versus yesterday, suggesting that option writers have not altered their positioning significantly in the last 24 hours. A stable strike points to a balanced open‑interest distribution across strikes, reinforcing the current magnet effect.
Expiry Context
As the September 29 expiry approaches (25 days left), the concentration of open interest around the ₹5,300 strike creates a natural incentive for the market to gravitate toward that level, because unwinding or exercising options becomes cheaper for writers. Nonetheless, max pain reflects a statistical tendency, not a guaranteed outcome; market forces, news, or liquidity can still drive the spot away from this strike.
Data Note
The spot‑to‑max‑pain gap is ₹110 (≈2.08 %) with 25 days remaining until expiration.
Data as of 2026-09-04